Livestreaming Platform Supported by:

custom image custom image custom image custom image

  0       0

33rd Annual North American Cystic Fibrosis Conference


S03--ET-NT-GMS: *Fixing What Modulators Won't


Oct 31, 2019 2:00pm ‐ Oct 31, 2019 3:45pm

Description

Currently available modulator therapies target the defective CFTR protein to restore function. Patients with genotypes that are refractory to treatment with extant, and on the horizon, modulators are a challenge for these small molecule approaches - as nonsense and other changes can prevent production of the CFTR protein, which these modulators target. This symposium will focus on emerging science and technologies that point a way forward for this population. The theme will be to: 1) discuss the cells that require CFTR restoration, 2) new ways to deliver non-small molecule payloads to those cells, 3) methods to evaluate success, and 4) an example of such a non-traditional approach in development.

Learning Objectives:

  • Summarize the cell types necessary to restore CFTR. 
  • Evaluate delivery methods for restoration of CFTR. 
  • Identify outcomes for success.

Note: Speaker Daniel Seigwart's presentation was not recorded at his request.

    Symposium Chair(s):

    Symposium Speaker(s):

    You must be logged in and own this session in order to post comments.

    Print Certificate
    Review Answers
    Print Transcript
    Completed on: token-completed_on
    Review Answers
    Please select the appropriate credit type:
    /
    test_id: 
    credits: 
    completed on: 
    rendered in: 
    * - Indicates answer is required.
    token-content

    token-speaker-name
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    token-index
    token-content
    /
    /
    token-index
    token-content
    token-index
    token-content